Global Transfection Reagents and Equipment Market Analysis 2018 to 2024: Dominated by Bio-Rad Laboratories, Roche Holding AG, Qiagen, Thermo Fisher Scientific, Sigma-Aldrich, MaxCyte, Others

This report includes professional and in-depth study about global transfection reagents and equipment market for the assessment period of 2018-2025. The major factors driving the growth are increasing prevalence of cancer and investments by pharmaceutical & biotechnological companies in R&D.

According to Data Bridge Market Research new Market report, “By Product Type (Reagents, Equipments), By Method (Biochemical { Lipofection, Calcium Phosphate, Deae-Dextran, Dendrimers}, Physical { Electroporation, Nucleofection, Sonoporation, Genegun, Magnetofection, Optoinjection}, Viral { Adenoviruses, Retroviruses, Adenoassociated Viruses}), By Application (Biomedical Research Protein Production { Gene Expression Studies, Cancer Research, Transgenic Models}, Therapeutic Deliver), By End-User (Pharmaceutical, Biotechnology Companies, Academics, Research Laboratories), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast is projected to reach USD 1480.12 million by 2025, at a CAGR of 8.4% during the forecast period of 2018 to 2025.

Click Here For Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-transfection-reagents-and-equipment-market

Global Transfection Reagents and Equipment Market

Transfection is a process of introducing genetic material such as DNA or RNA into eukaryotic cells to enable the production or expression of proteins using the cell’s own machinery. Transfection is a process that involves production of genetically modified cells with utilization of foreign nucleic acid .The process of transfection enables the study of gene functioning and expression, genetic mutations, and protein functioning. This technology helps the cells in mutation of cancer cells, protein metabolism by affecting the nuclear genes and regulation of gene therapy.

Oncology is expected to grow as the fastest growing segments. As per American Cancer Society, cancer is responsible for 1 in 8 deaths worldwide. Hence people conduct regular check-ups to look for the symptoms associated with it, leading to increase in the market.
According to national central cancer registry of China, there were 42,92,000 cases of cancer and 28,14,000 cancer deaths in China in the year 2015, which represents around 6.5% of the total population of china. A study was conducted by world health organization in Europe in 2012; it was found out that there are 3.7 million new cases of cancer every year and 1.9 million deaths each year in Europe.

Technological advancements in transfection reagents market are providing different alternatives to researchers. For instance, Amexa in July 2006 launched Nucleofector 96-well ShuttleTM System. The technology is used to deliver DNA or siRNA into cells to elucidate the function of genes. In addition to this, Axil scientific in 2018 launched a revolutionary solid-state platform with brand name Chromatrap. It enables more efficient, sensitive and robust chromatin immunoprecipitation (ChIP).

For More Details In-Depth Inquiry @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-transfection-reagents-and-equipment-market

Global Transfection Reagents and Equipment Market– Segmentation:

The global market transfection reagents and equipment market by the following sub-categories is presented

 By Product Type

• Reagents
• Equipment

 By Method

• Biochemical

o Lipofection
o Calcium Phosphate
o Deae-Dextran
o Dendrimers

• Physical

o Electroporation
o Nucleofection
o Sonoporation
o Genegun
o Magnetofection
o Optoinjection

• Viral

o Adenoviruses
o Retroviruses
o Adeno associated Viruses

 By Application

• Biomedical Research Protein Production

o Gene Expression Studies
o Cancer Research
o Transgenic Models

• Therapeutic Deliver

 By End-User

• Pharmaceutical
• Biotechnology Companies
• Academics
• Research Laboratories

 By Geography

• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa

FACTORS DRIVING GROWTH OF THE GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET

Increasing prevalence of cancer:

Cancer has a major impact on society across the world. It is estimated that in U.S. around 1,735,350 cases of cancer will be diagnosed and 609,640 People will die from the disease. The most common cancers are breast cancer, lung cancer, bronchus cancer, bladder cancer and many more.

Cancer mortality is lesser in women as compare to men (196.8 per 100,000 men and 139.6 per 100,000 women). Comparing on the basis of sex and race, cancer mortality is highest in African American men (239.9 per 100,000) and lowest in Asian/Pacific Islander women (88.3 per 100,000).

In 2017, an estimated 15,270 children and adolescents ages 0 to 19 were diagnosed with cancer and 1,790 died of the disease.

As per above data as the number of cancer cases increases, there will be rise in use of transfection reagents and equipment.

Increase in R&D investments by pharmaceutical & biotechnological companies:

Funding and federal agencies, such as National Science Foundation (NSF), are offering huge funding to the biotechnology sector to carry out investigational studies. Moreover, international funding bodies such as NIH and Welcome Trust are projected to play a crucial role in the growth of the market by providing funds for genetic research studies.

In August 2011 National institute of health and the Welcome Trust, a global charity based in London, have partnered to provide more than USD 37 million for genetic studies in Africa. The research focuses on the Human Heredity and Health in Africa project, non-communicable disorders such as heart disease and cancer.

TransIT-BrCa Transfection Reagent, is the first dedicated breast cancer cell line specific reagent available to researchers. It delivers efficiently many breast cancer cell types and maintains low cellular toxicity resulting in reduced experimental biases.

FuGENE HD Transfection Reagent offers unmatched transfection performance with minimal impact on cell physiology. It is ideal for use in a variety of applications, including transfection of cancer model cell lines, insect cells, stem cells, and for virus and protein production.
By the data provided above we can see that there are various funding, investments, research and developments made in biotechnology sector for transfection reagents and equipment.

View Full Report @ https://databridgemarketresearch.com/reports/global-transfection-reagents-and-equipment-market/

Top Key Players:

Some of the major market players in this market are Thermo Fisher Scientific Inc, Promega Corporation, F. Hoffmann-La Roche Ltd, QIAGEN, Bio-Rad Laboratories, Inc, Sigma-Aldrich Co, Illumina, Inc, New England Biolabs, Eppendorf AG, Agilent Technologies, ATCC, PerkinElmer Inc, Abcam plc, Merck KGaA, VWR International, LLC, ZYMO RESEARCH, BD, GENERAL ELECTRIC, National Center for Biotechnology Information, bioMérieux SA, Lonza, sigma-Aldrich Co, MaxCyte, Inc. among others.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.